PLIN2: a potential prognostic markers of early-stage atypical endometrial hyperplasia
Journal of Gynecologic Oncology · 2025
DOI: 10.3802/jgo.2025.36.e84 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gynecologic Oncology, 2025. Verfasst von Chao Lian und 6 weiteren Autor:innen. Beteiligte Einrichtung: Central Laboratory, Translational Medicine Research Center, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Endometrial Hyperplasia, Perilipin-2, Endometrial Neoplasms. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Natural Science Foundation of Jiangsu Province.
Abstract (Originalsprache)
OBJECTIVE: In the background of endometrial hyperplasia triggered by obesity and estrogen, could the perilipin 2 (PLIN2) serve as a possible prognostic marker for early atypical endometrial hyperplasia (AEH)? METHODS: A retrospective study examined blood lipid levels in endometrial cancer (EC) or AEH patients. An AEH mice model was established administrating with estradiol and/or high-fat (HF) diet. Hematoxylin and eosin staining were employed to assess pathological changes in the endometrium. Immunohistochemical staining were employed to evaluate the expression of adipose metabolism and endometrial hyperplasia proteins. The Cell Counting Kit-8 assay, cell colony-forming assays, and western blotting were utilized to verify the impact of oleic acid (OA) on HEC-1A cells. RESULTS: The retrospective study revealed elevated blood lipid levels among patients with EC or AEH. Prolonged HF diet stimulated the endometrium to exhibit features of complex atypical hyperplasia. In the early stage, PLIN2 (p=0.006) expression significantly increased with endometrial glandular hyperplasia. Both PLIN2 (p=0.008) and progesterone receptor (PR; p=0.019) exhibited elevated expression concurrent with simple endometrial hyperplasia. When AEH occurred, there were notable rise in the expression of PLIN2 (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Central Laboratory, Translational Medicine Research Center, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, China.
- Department of Obstetrics and Gynecology, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, China.
- Department of Pathology, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, China.
- Department of Obstetrics and Gynecology, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, China. jqchen68@hotmail.com.
- Department of Obstetrics and Gynecology, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, China. jurong@njmu.edu.cn.
ORCID-Profile: Chao Lian, Minling He, Chengcheng Zhao, Tianming Wang, Fang Tong, Jianquan Chen, Rong Ju
Förderung
- Natural Science Foundation of Jiangsu Province
Zitieren
APA
Lian, C., He, M., Zhao, C., Wang, T., Tong, F., Chen, J., & Ju, R. (2025). PLIN2: a potential prognostic markers of early-stage atypical endometrial hyperplasia. Journal of Gynecologic Oncology. https://doi.org/10.3802/jgo.2025.36.e84
Vancouver
Lian C, He M, Zhao C, Wang T, Tong F, Chen J, et al. PLIN2: a potential prognostic markers of early-stage atypical endometrial hyperplasia. Journal of Gynecologic Oncology. 2025. doi:10.3802/jgo.2025.36.e84
BibTeX
@article{Lian2025,
author = {Lian, Chao and He, Minling and Zhao, Chengcheng and Wang, Tianming and Tong, Fang and Chen, Jianquan and Ju, Rong},
title = {PLIN2: a potential prognostic markers of early-stage atypical endometrial hyperplasia},
journal = {Journal of Gynecologic Oncology},
year = {2025},
doi = {10.3802/jgo.2025.36.e84}
}
EUVIMED